Announcement PDF ASX ANNOUNCEMENT DISTRIBUTION OF SHARES BY SUBSTANTIAL SHAREHOLDER MELBOURNE (AUSTRALIA) 4 December 2020: Invion Limited (ASX: IVX) (Invion) has been advised by Unlimited Innovation Group Limited (UIG), the company’s largest shareholder holding 50.8% of Invion’s shares, that UIG has completed an in-specie distribution of the Invion shares held by it to the members of UIG. Invion has further been informed by UIG that, to ensure the distribution of shares by UIG to its members occurs in an orderly manner, the UIG members have agreed with UIG to enter into voluntary escrow arrangements ranging between 3 to 12 months, a summary of which is provided below. Description Escrow expiry Quantity of securities No. of holders IVX 3 months escrow shares till 01/03/2021 (IVXESC0321) 01/03/2021 1,432,841,408 16 holders IVX 6 months escrow shares till 01/06/2021 (IVXESC0621) 01/06/2021 1,160,779,413 32 holders IVX 12 months escrow shares till 01/12/2021 (IVXESC1221) 01/12/2021 220,682,156 1 holder Invion is not a party to the escrow arrangements but UIG has provided assurances to Invion's board that it will enforce these arrangements. A current statement setting out the names of the 20 largest shareholders of fully paid ordinary shares and the percentage held by each is attached. This announcement is authorised by the Board of Invion. ___________________________________ Investor and Media enquiries: Thian Chew (Chairman) T: +61 3 9692 7222 E: investor@inviongroup.com Brendon Lau (Investor & Media Relations) T: +61 409 341 613 E: brendon@vantagepointpartners.com.au Invion Limited ABN 76 094 730 417 Level 4, 100 Albert Road, South Melbourne, VIC, 3205, Australia P: +61 9692 7222 W: www.inviongroup.com ASX ANNOUNCEMENT INVION LIMITED Top holders Security: Top holders: ORD.ASX [ORDINARY + ESCROW ORDINARY] 20 Rank Nam e 1 2 3 4 5 6 7 8 9 10 11 12 13 14 14 15 16 17 18 19 20 A/C designation POLAR VENTURES LIMITED NGPDT GREATER CHINA LIMITED MR HONSUE CHO ACSLNC PTY LTD RMWC PTY LTD YONG CHEN BNP PARIBAS NOMINEES PTY LTD HONG DENG SHENGLI WANG GRAEME ERIC SCOTT MING KIT HUI RMWC PTY LTD SHUBO MIAO SHENGWEI OU MAK SIEW WEI EQ INVESTMENT PTY LTD PLATINUM HOMES LTD SOO CORP PTY LTD YINGHUA MA HONGHUI CHEN CITICORP NOMINEES PTY LIMITED ACSLNC FAMILY RMWC FAMILY <IB AU NOMS RETAILCLIENT DRP> <RMWC FAMILY A/C> Total Balance of register Grand total 02 Dec 2020 %IC 545,217,721 545,152,297 284,626,482 267,250,000 220,682,156 200,000,000 156,489,665 141,739,597 136,288,074 118,750,000 96,666,667 93,865,000 73,333,333 66,666,667 66,666,667 62,500,000 62,333,333 56,666,666 54,000,000 52,786,440 47,746,624 3,349,427,389 2,179,614,906 5,529,042,295 9.86 9.86 5.15 4.83 3.99 3.62 2.83 2.56 2.46 2.15 1.75 1.70 1.33 1.21 1.21 1.13 1.13 1.02 0.98 0.95 0.86 60.58 39.42 100.00 About Invion Invion is a life-science company that is leading the global research and development of PhotosoftTM technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand license rights to the PhotosoftTM technology. Research and clinical trials are funded by the technology licensor, RMW Cho Group Limited, via an R&D services agreement with the Company. Invion is listed on ASX (ASX:IVX). This announcement was approved for release by the Board of Invion Limited. For further information please contact investor@inviongroup.com. About Photodynamic Therapy (PDT) Invion is developing Photosoft™ technology as an improved next generation Photodynamic Therapy. PDT uses non-toxic photosensitisers and visible light in combination with oxygen to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumours and stimulates the immune system. A potential alternative to surgery, and in contrast to radiotherapy and chemotherapy which are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumour by leukocytes. Invion Limited ABN 76 094 730 417 Level 4, 100 Albert Road, South Melbourne, VIC, 3205, Australia P: +61 9692 7222 W: www.inviongroup.com